Injectable Drug Recall: TRI-MIX 30/1/10 Vials Lack Sterility Assurance
Carolina Infusion is recalling TRI-MIX 30/1/10 injectable vials nationwide because the sterility of the product cannot be assured. This FDA Class II recall affects 16 vials distributed across multiple lots with expiration dates through October 2022.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall of an injectable product with compromised sterility assurance, which poses significant risk of serious infection if administered. No illnesses have been reported, making this a precautionary recall based on manufacturing/quality assurance failure rather than known harm.
Plain-English summary
Carolina Infusion LLC is recalling TRI-MIX 30/1/10 Injectable (10 mL vials) nationwide due to lack of assurance of sterility. The recall affects 16 vials distributed in multiple lots with manufacturing dates between June 2 and August 19, 2022.
Injectable medications must maintain strict sterility to prevent serious infections. This is an FDA Class II recall, indicating a quality assurance failure with potential for serious harm if sterile conditions were compromised. The manufacturer cannot verify that the recalled vials meet sterility standards.
Patients and healthcare providers with access to affected vials should discontinue use immediately and contact their healthcare provider for guidance. The FDA maintains a complete list of affected lot numbers and expiration dates (ranging from August 27, 2022, to October 18, 2022) on its website.
The recalled product
- Product
- TRI-MIX 30/1/10 Injectable, 10 ML vial, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.
- Manufacturer
- Carolina Infusion
- Category
- Drug — Injectable
- Hazard
- Affected units
- 16
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lots: 06282022@1
- BUD: 08/27/2022
- 06292022@8
- BUD: 08/28/2022
- 07012022@19
- BUD: 08/30/2022
- 07012022@3
- 07122022@8
- BUD: 09/10/2022
- 07132022@9
- BUD: 09/11/2022
- 07192022@1
- BUD: 09/17/2022
- 07292022@9
- BUD: 09/27/2022
- 08032022@10
- BUD: 10/02/2022
- 08092022@2
- BUD: 10/08/2022
- 08102022@1
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 20 recalled by Carolina Infusion under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 20 products in this recall →Related recalls
Same manufacturer · Carolina Infusion
See all →- HighInjectable drug product recalled for lack of sterility assurance
FDA (Drugs) · 2022-09-21
- HighInjectable Steroid Product Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-09-21
- HighInjectable testosterone product recalled for sterility assurance defect
FDA (Drugs) · 2022-09-21
- HighInjectable Medication TRI-MIX Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-09-21
- HighSermorelin Acetate Injectable Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2022-09-21
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29